GPT-4b micro: Yamanaka factor variants with over 50-fold higher expression
OpenAI and Retro Biosciences used a specialized model to design Yamanaka factor variants that produced over 50-fold higher expression of reprogramming markers in vitro than controls, with results replicated across multiple donors, cell types, and delivery methods, and pluripotency confirmed. Reported by OpenAI; the model is not publicly available.
Technology: GPT-4b micro
Publication: Announcement only · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Announcement only
- Test type: direct test
- Tested: Designed Yamanaka factor variants were tested in vitro across multiple donors, cell types and delivery methods, with over 50-fold higher expression of reprogramming markers and pluripotency confirmed relative to controls.
- Still unknown: The page gives no detailed protocol or data, the model is not publicly available, and the results are reported by OpenAI only.
- AI role: A specialized GPT-4b micro model designed Yamanaka factor variants.
Evidence sources: https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: blog. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.